Company Filing History:
Years Active: 1977-1979
Title: George Madison Sieger: Innovator in Pharmaceutical Treatments
Introduction
George Madison Sieger is a notable inventor based in Montvale, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of topical inflammation and the development of sustained release forms of certain medications. With a total of 2 patents, Sieger's work has had a meaningful impact on medical treatments.
Latest Patents
Among his latest patents, one focuses on a method of treating topical inflammation in mammals. This involves the administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.alpha.-fluoro-11.beta.,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate in a pharmaceutically acceptable carrier. Another patent pertains to sustained release forms of certain oxazepines for parenteral use. This patent describes a sustained release depot form of the free base or pamoate salt of 2-chloro-11-(1-piperazinyl)-dibenz[b,f][1,4]-oxazepine or 2-chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f]-[1,4]oxazepine in an injectable oil for parenteral administration.
Career Highlights
George Madison Sieger has been associated with the American Cyanamid Company, where he has utilized his expertise to advance pharmaceutical innovations. His work has contributed to the development of effective treatments that address various medical conditions.
Collaborations
Throughout his career, Sieger has collaborated with notable colleagues, including James Elwood Krueger and Arnold Curtis Osterberg. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
George Madison Sieger's contributions to pharmaceutical inventions highlight his dedication to improving medical treatments. His patents reflect a commitment to innovation that continues to benefit the field of medicine.